PL BioScience Announces Exclusive Distributorship Agreement with SPI

PL BioScience CEO & Co-Founder, Dr. Hatim Hemeda, and Mr. Tetsuo Miura, Head of Discovery and Development Division, SPI.

PL BioScience Announces Exclusive Distributorship Agreement with SPI

PL BioScience announces Distributorship Agreement with SPI

PL BioScience announces Exclusive Distributorship Agreement with Summit Pharmaceuticals International (SPI)

PL BioScience GmbH is proud to announce an exclusive distribution agreement for the Japanese market with Summit Pharmaceuticals International Corporation (SPI) to support local availability of Gamma-Irradiated ELAREM™ Ultimate-FD PLUS Human Platelet Lysate and the broader ELAREM™ platform for clinical and research applications.

Read our Press Release here.

Any questions?
close slider

Any questions?

Please contact us:

support@pl-bioscience.com

+49 (0) 241 95719-100